INTRODUCTION
============

Anaphylaxis is an immediate, immunoglobulin E (IgE)-mediated hypersensitivity reaction resulting from the sudden release of mast cell- and basophil-derived chemical mediators such as histamine, serotonin, newly synthesized lipid-derived mediators, such as prostaglandin D~2~ (PGD~2~), leukotriene B~4~ (LTB~4~) cysteinyl leukotrienes LTC~4~, LTD~4~, and LTE~4~, platelet-activating factor (PAF), and various cytokines ([@b13-27-34_bt22-1]; [@b29-27-34_bt22-1]). Furthermore, the releases of these chemical mediators are a consequence of the binding of IgE to FcεRI on the surfaces of mast cells. This initial interaction results in the phosphorylations of tyrosine residues in the immune receptor tyrosine based activation motif (ITAM) of the β and γ subunits of FcεR1 by Lyn and recruits the tyrosine kinase Syk, which is required for phosphorylation of linker for activation of T cells (LAT). Phosphorylated LAT binds phospholipase Cγ (PLCγ) and the adaptors Gads and Grb2 and generates inostitol-1,4,5-triphospahte (IP~3~), which can increase intracellular calcium release from endoplasmic reticulum (ER) calcium stores ([@b30-27-34_bt22-1]). Elevated intracellular calcium then triggers the degranulation and the translocation of cytosolic phospholipase A~2~ (cPLA~2~) and 5-lipoxygenase (5-LO) to the nuclear membrane. The syntheses of cyclooxygenase-2 (COX-2)-dependent PGD~2~ and of 5-LO-dependent LTC~4~ in mast cells are initiated by the release of free arachidonic acid (AA) from membrane phospholipid by cPLA~2~ ([@b15-27-34_bt22-1]; [@b38-27-34_bt22-1]). Furthermore, it is well known that COX-2 dependent PGD~2~ is very important to the development of inflammation and allergic disease such as asthma ([@b27-27-34_bt22-1]). LTC~4~ plays important roles in inflammatory and allergic diseases ([@b36-27-34_bt22-1]), and increasing evidence suggests it play a role in cancer ([@b3-27-34_bt22-1]) and cardiovascular disease ([@b22-27-34_bt22-1]). Therefore, the inhibition of eicosanoid production constitutes an important therapeutic strategy against various allergic inflammatory diseases.

Curcumin (diferuloyl methane) is a major constituent of the rhizome of Curcuma longa, and is used traditionally to treat inflammation, gastrointestinal disorders, hepatic disorders, diabetic wounds, skin wounds, rheumatism, sinusitis, and other disorders ([@b1-27-34_bt22-1]). Furthermore, scientific studies have shown that curcumin inhibits histamine release and the secretions of tumor necrosis factor-α (TNF-α) and interleukin-4 (IL-4) from mast cells triggered by IgE, calcium ionophore A23187, or compound 48/80 ([@b32-27-34_bt22-1]; [@b16-27-34_bt22-1]; [@b5-27-34_bt22-1]). Curcumin has also been reported to inhibit IgE-induced type I hypersensitivity and ovalbumin-induced airway hyperreactivity ([@b37-27-34_bt22-1]; [@b25-27-34_bt22-1]; [@b16-27-34_bt22-1]), and to inhibit COX-2 gene expression in phorbol ester-treated human gastrointestinal epithelial cells and mouse skin ([@b6-27-34_bt22-1]; [@b27-27-34_bt22-1]) and *in vitro* lipoxygenase and cyclooxygenase activities in mouse epidermis ([@b11-27-34_bt22-1]). However, the effect of curcumin on IgE/Ag-induced COX-2 dependent PGD~2~ and 5-LO dependent LTC~4~ generation in mast cells and IgE-mediated systemic anaphylactic response have not been well investigated.

In this study, we evaluated the effects of curcumin on the generation of eicosanoid (PGD~2~ and LTC~4~) in FcεRI-induced mast cells and on passive systemic anaphylaxis (PSA) response in mice.

MATERIALS AND METHODS
=====================

Plant material
--------------

Curcumin was isolated from the ethyl acetate fraction of a methanol extract of the rhizome of Curcuma longa, as described previously ([@b14-27-34_bt22-1]), and produced a single TLC spot and had a HPLC determined purity of \>99.5%. Curcumin was prepared by dissolving it in dimethyl sulfoxide (DMSO). The final concentration of DMSO in culture media was adjusted to 0.1% (v/v). DMSO alone was run as a control in all cases.

Chemicals and reagents
----------------------

Mouse anti-dinitrophenyl (DNP) IgE and DNP-human serum albumin (HSA) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Fexofenadine-HCl (Fexo), a histamine H1 receptor antagonist, was obtained from Korea Pharma (Seoul, Korea). The rabbit polyclonal antibodies specific for phospho-IκB, IKKα/β, ERK1/2, JNK, p38, Akt, β-actin, and total form for IκB, ERK1/2, JNK, p38, and Akt were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Rabbit polyclonal antibodies for phospho-cPLA~2~α (Ser505), cPLA~2~α, 5-LO, PLCγ1, IKKα/β lamin B and NF-κB p65 as well as secondary goat anti-rabbit IgG-HRP and rabbit anti-goat IgG-HRP antibodies, total Syk, total LAT, and Bay 61-3606 were purchased from Santa Cruz Biotechnology (Dallas, Texas, USA) and antibodies for phosphotyrosine was purchased from Millipore (Millipore, Billerica, MA, USA). The antibody-reactive bands were visualized with an enhanced chemiluminescence (ECL) system (Pierce Biotechnology, Rockford, IL, USA). The enzyme immnoassay (EIA) kits for PGD~2~, LTC~4~, histamine and the antibody for COX-2 were purchased from Cayman Chemicals (Ann Arbor, MI, USA).

Culture and activation of bone marrow derived mast cells (BMMCs)
----------------------------------------------------------------

BMMCs were isolated from bone marrow of C57BL/6 mice and differentiated as described previously ([@b20-27-34_bt22-1]). Briefly, BMMCs were cultured in RPMI 1640 medium containing 10% fetal bovine serum, 100 U/ml penicillin, 10 mM HEPES, 100 μM MEM non-essential amino acid solution (Invitrogen, Grand Island, NY, USA) and 20% pokeweed mitogen-spleen cell conditioned medium as a source of IL-3. For stimulation, 106 cells/ml were sensitized overnight with 500 ng/ml anti-DNP IgE, pretreated with indicated concentration of curcumin or Bay 61-3606, and stimulated for appropriate periods with 100 ng/ml DNP-HSA. The reactions were terminated by centrifugation of the cells at 3,000 rpm for 5 min at 4°C.

Determination of LTC~4~ and PGD~2~
----------------------------------

Concentration of LTC~4~ and PGD~2~ were determined as described previously ([@b20-27-34_bt22-1]). IgE sensitized BMMCs suspended in enriched medium at a cell density of 1×10^6^ cells/ ml were pretreated with indicated concentration of curcumin or Bay 61-3606 for 1 h and stimulated with DNP-HSA for 15 min. Supernatants were isolated for further analysis by EIA kit. The concentration of LTC~4~ was determined using an EIA kit. To assess COX-2-dependent PGD~2~ synthesis, BMMCs were preincubated with 1 μg/ml of aspirin for 2 h to irreversibly inactivate preexisting COX-1. After washing, BMMCs were incubated with 100 ng/ml DNP-HSA at 37°C for 7 h in the presence of curcumin or Bay 61-3606. PGD~2~ in the supernatants were quantified using PGD~2~ EIA kit and cells were used for immunoblots analysis. Under the conditions employed, LTC~4~ reached 4.75 ng/10^6^ cells and PGD~2~ generation reached 2.12 ng/10^6^ cells. All data were the arithmetic mean of triplicate determinations.

Measurement of intracellular Ca^2+^ level
-----------------------------------------

Intracellular Ca^2+^ levels were determined using FluoForte™ Calcium Assay Kit (Enzo Life Sciences, Ann Arbor, MI, USA), as described previously ([@b12-27-34_bt22-1]). Briefly, BMMCs (1×10^6^ cells) were sensitized overnight with 500 ng/ml anti-DNP IgE. Sensitized BMMCs were preincubated with FluoForte™ Dye-Loading Solution for 1 h at room temperature. After washing the dye from cell surface with HBSS, cells (5×10^4^) were seeded into 96-well microplates and pretreated with curcumin or Bay 61-3606 for 1 h before adding DNP-HSA. Fluorescence was measured using a fluorometric imaging plated reader at an excitation wavelength of 485 nm and an emission wavelength of 520 nm on a BMG Labtechnologies FLUOStar OPITIMA platereader (Offenburg, Germany).

Preparation of nuclear and cytoplasmic extracts
-----------------------------------------------

The nuclear and cytoplasmic extracts were prepared as described previously ([@b20-27-34_bt22-1]). BMMCs were sensitized to DNP-specific IgE (500 ng/ml, overnight) and pretreated with curcumin or Bay 61-3606 for 1 h, and then stimulated with DNP-HSA (100 ng/ml) for 30 min. Cultured BMMCs were collected by centrifugation, washed with PBS, and lysed in a buffer containing 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 1 mM PMSF and 0.1% NP40 on ice for 10 min. Supernatants (cytosolic fractions) were obtained by centrifugation at 1,000 *g* for 4 min. Nuclear pellets were washed and lysed in a buffer containing 20 mM HEPES (pH 7.9), 25% (v/v) glycerol, 420 mM NaCl, 1.5 mM MgCl~2~, 0.2 mM EDTA, and protease inhibitor cocktail.

Immunoprecipitation (IP)
------------------------

Immunoprecipitation was performed as described previously ([@b12-27-34_bt22-1]). Briefly, cell lysates were obtained using modified lysis buffer \[0.1% Nonidet P-40, 50 mM HEPES (pH 7.0), 250 mM NaCl, 5 mM EDTA, 1 mM PMSF, and 0.5 mM dithiothreitol\]. Total cell lysates (1 mg protein equivalent) were incubated with anti-Syk or anti-LAT antibodies for 2 h at 4°C and immunocomplexes were precipitated with 20 μl of protein A-Sepharose and washed 3 times with ice-cold lysis buffer. Precipitates and total cell lysates were subjected to SDS-PAGE and immunoblotted with appropriate antibodies.

Immunoblotting
--------------

Immunoblotting was performed as described previously ([@b20-27-34_bt22-1]). Cells were lysed in RIPA lysis buffer (50 mM Tris-HCl \[pH 8.0\], 150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 1mM phenylmethanesulfonylfluoride (PMSF), 1M dithiothreitol (DTT), 200 mM NaF, 200 mM Na~3~VO~4~, and protease inhibitor cocktail). Cell debris was removed by centrifugation at 14,000 *g* for 15 min at 4°C, and the resulting supernatant was western blotted. Protein concentration was measured using a Qubit Fluorometer (Invitrogen, USA). Samples were separated by 8% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to nitrocellulose membranes (Millipore, Billerica, MA, USA). Immunoreactive proteins were incubated with HRP-coupled secondary antibodies diluted at 1:3,000 for 1 h at room temperature, and then developed using an enhanced chemiluminescence (ECL) detection kit.

Passive systemic anaphylaxis (PSA) reaction in mice
---------------------------------------------------

PSA was induced as described previously ([@b20-27-34_bt22-1]). Six ICR mice (Hyochang Science, Daegu, Korea) were placed per cage within a laminar airflow cabinet and fed standard laboratory chow (Purina, Seoul, Korea) and provided with water *ad libitum*. The animals were maintained in 22 ± 1°C, 55 ± 10% RH environment under a 12 h/12 h (light/dark) cycle for at least 7 days prior to experiments. Mice were injected with 2 μg of DNP-specific IgE in 100 μl of saline or with 100 μl of saline. 24 h later mice were orally administered curcumin (20 and 50 mg/kg) or fexofenadine-HCl (Fexo; 50 mg/kg) and 1 h later challenged with 4 mg *i.v.* of DNP-HSA in 200 μl of saline. Blood was collected by cardiac puncture 5 min after the Ag challenge. Serum LTC~4~, PGD~2~ and histamine concentrations were determined using appropriate EIA kits. All experiments using animals were approved beforehand by the Institutional Animal Care and Use Committee of Yeungnam University.

Statistical analysis
--------------------

All experiments were performed three or more times. Average values are expressed as means ± S.D. Statistical analyses were performed using SPSS 19.0 (SPSS, Chicago, IL, USA). The Student's *t*-test was used to compare pairs of independent groups. Statistical significance was accepted for *p* values \<0.05.

RESULTS
=======

Curcumin suppressed passive systemic anaphylaxis (PSA) in mice
--------------------------------------------------------------

Anaphylaxis is an IgE-mediated hypersensitivity reaction caused by the release of various inflammatory mediators due to binding of specific IgE to FcεRI on the surfaces of mast cells or basophils ([@b30-27-34_bt22-1]). Furthermore, it has been reported that curcumin suppresses IgE or compound 48/80 induced passive cutaneous anaphylaxis ([@b32-27-34_bt22-1]; [@b16-27-34_bt22-1]; [@b5-27-34_bt22-1]). However, no report has been issued on the effect of curcumin on PSA in mice. Therefore, we assessed the anti-allergic-inflammatory effects of curcumin using a mouse PSA model. As shown in [Fig. 1](#f1-27-34_bt22-1){ref-type="fig"}, PSA was induced using an *i.v.* injection of DNP-HSA in ICR mice after the oral administration of 25 or 50 mg/kg of curcumin or 50 mg/kg of Fexo ([@b7-27-34_bt22-1]). One hour later, curcumin reduced serum LTC~4~ ([Fig. 1A](#f1-27-34_bt22-1){ref-type="fig"}), PGD~2~ ([Fig. 1B](#f1-27-34_bt22-1){ref-type="fig"}) and histamine ([Fig. 1C](#f1-27-34_bt22-1){ref-type="fig"}) levels in a dose-dependent manner (n=6). The suppressive effect of 50 mg/kg of curcumin was similar to that of 50 mg/kg of Fexo, a histamine H1 receptor antagonist.

Curcumin inhibited LTC~4~ generation and Ca^2+^ influx in IgE/Ag-induced BMMCs
------------------------------------------------------------------------------

*In vivo* results let us to investigate the action mechanism responsible for the anti-allergic inflammatory activities of curcumin using mast cells, major players in PSA. LTC~4~ is metabolites of arachidonic acid derived from action of 5-LO/LTC~4~ synthase in mast cells, and LTC~4~ have been implicated in inflammation, proliferation and allergic conditions like asthma ([@b24-27-34_bt22-1]). Thus, we investigated the effects of curcumin on 5-LO dependent LTC~4~ generation in BMMCs. As shown in [Fig. 2A](#f2-27-34_bt22-1){ref-type="fig"}, curcumin strongly inhibited LTC~4~ generation in a dose-dependent manner. It is well known that Ca^2+^ is essential for arachidonic acid (AA) release from phospholipid and degranulation in IgE/Ag-induced mast cells ([@b15-27-34_bt22-1]; [@b38-27-34_bt22-1]), thus we examined the effect of curcumin on intracellular Ca^2+^ influx in IgE/Ag-induced BMMCs. As shown in [Fig. 2B](#f2-27-34_bt22-1){ref-type="fig"}, intracellular Ca^2+^ level in activated BMMCs was about three fold higher than in resting cells, and this increase was dose-dependently inhibited by curcumin. Bay 61-3606 (a Syk inhibitor) also strongly decreased intracellular LTC~4~ generation as well as Ca^2+^ influx. Consistent with a previous report ([@b16-27-34_bt22-1]), the release of β-Hex (a degranulation marker enzyme) was dose-dependently inhibited by curcumin (data not shown).

Curcumin inhibited cPLA~2~ phosphorylation, translocation of phospho-cPLA~2~α and 5-LO and activation of MAPKs
--------------------------------------------------------------------------------------------------------------

Recently, we and other group have reported that the release of free AA from membrane phospholipid in activated mast cells requires the phosphorylation of cPLA~2~α (p-cPLA~2~α) by mitogen activated protein kinases (MAPKs) ([@b18-27-34_bt22-1]; [@b20-27-34_bt22-1]), and the translocation of p-cPLA~2~α is dependent on intracellular Ca^2+^ influx ([@b9-27-34_bt22-1]; [@b20-27-34_bt22-1]). To determine whether curcumin inhibits the phosphorylation and translocation of cPLA~2~α, we pretreated BMMCs with different concentrations of curcumin or Bay 61-3606. As show in [Fig. 3A](#f3-27-34_bt22-1){ref-type="fig"}, curcumin dose-dependently inhibited the phosphorylation (C-p-cPLA~2~α) and translocation of C-p-cPLA~2~α to the nuclear envelope (N-p-cPLA~2~α). The synthesis of 5-LO dependent LTC~4~ in IgE/Ag-induced mast cells is known to mediate the translocations of both p-cPLA~2~α and 5-LO to the nuclear envelope ([@b35-27-34_bt22-1]; [@b20-27-34_bt22-1]; [@b19-27-34_bt22-1]). Thus, we investigated the effect of curcumin on the translocation of 5-LO to the nuclear envelope. As was expected, curcumin or Bay 61-3606 inhibited the translocation of cytosolic 5-LO (C-5-LO) to nuclear envelope (N-5-LO). Next, to confirm that the inhibition of cPLA~2~α phosphorylation by curcumin occurred via the inhibition of MAPKs phosphorylation including extracellular regulated kinase1/2 (ERK1/2), cjun N-terminal kinase (JNK), and p38 MAP kinase, therefore we examined the effect of curcumin or Bay 61-3606 on the phosphorylation of MAPKs. As shown in [Fig. 3B](#f3-27-34_bt22-1){ref-type="fig"}, curcumin or Bay 61-3606 inhibited the phosphorylations of three MAPKs in a dose dependent manner.

Curcumin inhibits COX-2 dependent PGD~2~ generation and NF-κB activation
------------------------------------------------------------------------

In mast cells, unlike 5-LO dependent LTC~4~ generation, PGD~2~ generation occurs in a biphasic manner. Immediate PGD~2~ generation (occurring within 2 h), is associated with COX-1, and delayed PGD~2~ generation (during 2--10 h) is occurred by inducible COX-2 protein ([@b2-27-34_bt22-1]; [@b23-27-34_bt22-1]). To assess COX-2-dependent delayed PGD~2~ generation, BMMCs were pre-treated with aspirin to abolish preexisting COX-1 activity, followed by a brief wash, and then stimulated with Ag for 7 h with or without curcumin. As shown in [Fig 4A](#f4-27-34_bt22-1){ref-type="fig"}, delayed PGD~2~ generation was dose-dependently inhibited by curcumin, with a concomitant suppression of COX-2 protein expression. Yu *et al*., reported that the Syk downstream molecules PI3K/Akt pathway affects transcription factor NF-κB activation in gastric cancer cells and mast cells ([@b39-27-34_bt22-1]; [@b20-27-34_bt22-1]) and NF-κB has been identified as an essential transcription factor for the induction of several inflammatory mediators including, TNF-α, COX-2, and inducible NO synthase ([@b26-27-34_bt22-1]; [@b33-27-34_bt22-1]; [@b20-27-34_bt22-1]). Thus, we examined the effect of curcumin on Akt/NF-κB axis activation. When IgE-sensitized BMMCs were pretreated with curcumin for 1 h and then stimulated with Ag for 15 min, phosphorylation of the Akt, IKK complex (p-IKKα/β) and IκBα (p-IκBα) was increased, with a concomitant decrease of total IκBα and nuclear translocation of NF-κB (C-NF-κB). As shown in [Fig. 4B](#f4-27-34_bt22-1){ref-type="fig"}, both curcumin and Bay 61-3606 inhibited the phosphorylations of Akt, IKKα/β, IκBα, IκBα degradation and the translocation of cytosolic p65 to nuclear (N-NF-κB), suggesting that Syk mediated Akt/NF-κB pathway regulate the reduction of COX-2 dependent PGD~2~ by curcumin.

Curcumin inhibited the Syk pathway in IgE/Ag-induced BMMCs
----------------------------------------------------------

Previously, we and others reported that Syk plays an essential role in the initiation of FcεRI-induced mast cells activation and mediates LAT, resulting in the activation of downstream signaling, including MAPKs, phosphatidylinositide 3-kinase (PI3K), and PLCγ ([@b18-27-34_bt22-1]; [@b20-27-34_bt22-1]). Furthermore, it has been reported that curcumin inhibited the releases of TNF-α and IL-4 from mast cells via a Syk dependent pathway, and that the inhibitions of these secretions by curcumin is dependent on its direct inhibition of Syk kinase activity rather than Syk phosphorylation ([@b16-27-34_bt22-1]). To determine whether curcumin affects Syk phosphorylation in IgE/Ag-induced BMMCs, we examined the effects of curcumin on the phosphorylation of Syk and its downstream signal molecules LAT and PLCγ1. As shown in [Fig. 5A](#f5-27-34_bt22-1){ref-type="fig"}, curcumin did not affect Syk phosphorylation, but significantly and dose-dependently inhibited the phosphorylations of LAT and PLCγ1 ([Fig. 5B, C](#f5-27-34_bt22-1){ref-type="fig"}), as previously reported ([@b16-27-34_bt22-1]). Bay 61-3606 (the Syk inhibitor used as a positive control) completely inhibited the phosphorylations of Syk, LAT and PLCγ1. These results suggest that curcumin inhibits PGD~2~, LTC~4~, and degranulation by regulating the Syk signal pathway.

DISCUSSION
==========

Curcumin has been shown to have diverse biological activities, such as, antioxidant, anti-allergic, anti-inflammatory, antiviral, antibacterial, antifungal, and anticancer activities ([@b1-27-34_bt22-1]). Several groups have reported that curcumin shows anti-allergic activity through the inhibition of histamine release, TNF-α and IL-4 from activated mast cells and *in vivo* type I hypersensitivity animal model ([@b37-27-34_bt22-1]; [@b25-27-34_bt22-1]; [@b16-27-34_bt22-1]). In addition, curcumin also suppresses arachidonic acid metabolizing enzymes such as cPLA~2~ phsophorylation, COX-2 expression and recombinant 5-LO activity in LPS-stimulated RAW 264.7 cells and A23187-stimulated HT human colon cancer cells ([@b10-27-34_bt22-1]) and inhibits *in vitro* LOX and COX activities in TPA-and arachidonic acid-induced inflammation in mouse epidermis ([@b11-27-34_bt22-1]). Furthermore, Curcumin modulates the inflammatory response by down-regulating the activity of COX-2 and inducible nitric oxide synthase (iNOS) enzymes through suppression of NF-κB activation ([@b31-27-34_bt22-1]). Even though they reported that curcumin inhibited generation of COX-dependent PGs and LOX-dependent hydroxyeicosatetraenoic acids (HETEs), previous reports were mainly examined as a part of anticancer activity of curcumin. However, the effect of curcumin on generation of COX-2 dependent PGD~2~ and 5-LO dependent LTC~4~ generation in IgE/Ag-induced mast cells and IgE-mediated PSA reaction have not been studied to date. Therefore, we investigated the effects of curcumin on the generation of eicosanoid (PGD~2~ and LTC~4~) in BMMCs and on PSA reaction in mice. It has been well established that lipid mediators, like LTC~4~ and PGD~2~, are closely associated with various allergic and inflammatory diseases ([@b36-27-34_bt22-1]; [@b27-27-34_bt22-1]). Thus, the inhibition of LTC~4~ and PGD~2~ generation by mast cells is an important therapeutic strategy in the context of allergic-inflammatory disease. The aim of this study was to investigate the effect of curcumin on IgE/Ag-induced COX-dependent PGD~2~ and 5-LO dependent LTC~4~ generation in BMMCs and on IgE-induced passive systemic anaphylaxis (PSA) in mice. IgE binds to FcεRI on mast cells, the Syk-LAT axis activates PLCγ, which increases intracellular Ca^2+^ influx and leads to degranulation and eicosanoid production ([@b30-27-34_bt22-1]). As described above, IgE binds to FcεRI on BMMCs, it promptly elicits 5-LO dependent LTC~4~ generation, which is inhibited dose-dependently by curcumin ([Fig. 2A](#f2-27-34_bt22-1){ref-type="fig"}). It has been reported that the synthesis of LTC~4~ in mast cells is regulated by two steps, namely, AA release from phospholipid by cPLA~2~α, MAPKs-mediated phosphorylation of cPLA~2~α and the conversion of free AA to LTC~4~ by 5-LO ([@b8-27-34_bt22-1]). Translocation of both 5-LO and phospho-cPLA~2~α (C-p-cPLA~2~α) to the nuclear envelope are depend on the increase of cytosolic Ca^2+^ level ([@b35-27-34_bt22-1]; [@b20-27-34_bt22-1]; [@b19-27-34_bt22-1]). The present study showed that curcumin inhibited the translocations of both enzymes, which concurred with its observed inhibitory effect on intracellular Ca^2+^ influx ([Fig. 2B](#f2-27-34_bt22-1){ref-type="fig"}). Next, to elucidate the effect of curcumin on COX-2 dependent delayed PGD~2~ generation, BMMCs were pre-treated with aspirin to abolish preexisting COX-1 activity, and then stimulated with Ag for 7 h with or without curcumin. We found that curcumin also suppressed COX-2 expression and attendant PGD~2~ generation ([Fig. 4A](#f4-27-34_bt22-1){ref-type="fig"}). It has been previously reported that curcumin inhibited the TPA-induced up-regulation of COX-2 and MMP-9 by suppressing ERK1/2 phosphorylation and NF-κB transactivation in epithelial cells ([@b17-27-34_bt22-1]), and that it exerts anti-inflammatory effects by inhibiting the NF-κB and MAPKs pathways ([@b4-27-34_bt22-1]). Recently, we also reported that COX-2-dependent PGD~2~ generation and COX-2 expression in BMMCs occurs via the activation of the NF-κB and MAPKs pathways ([@b20-27-34_bt22-1]; [@b19-27-34_bt22-1]), thus we investigated the effect of curcumin on the MAPKs and NF-κB pathways in IgE/Ag-induced BMMCs. As shown in [Fig. 3B](#f3-27-34_bt22-1){ref-type="fig"}, curcumin suppressed the phosphorylations of ERK1/2, JNK, and p38 MAP kinase in a dose dependent manner, which implied that it affects the phosphorylation and translocation of cPLA~2~. Since curcumin or Bay 61-3606 suppressed intracellular Ca^2+^ influx ([Fig. 2B](#f2-27-34_bt22-1){ref-type="fig"}), MAPKs phosphorylation ([Fig. 3B](#f3-27-34_bt22-1){ref-type="fig"}) and Akt/ NF-κB axis activation, these results suggest that Syk plays an important role in the generation of PGD~2~ and LTC~4~ in IgE/Ag-induced BMMCs. Therefore, we examined whether curcumin affects the phosphorylation of Syk in IgE/Ag-induced BMMCs. In agreement with a previous report ([@b16-27-34_bt22-1]), curcumin was found not to directly inhibit the phosphorylation of Syk, but to inhibit the phosphorylations of LAT and PLCγ1 which lie downstream of Syk. In view of the effect of phosphorylated PLCγ1 on inositol phospholipid turnover and the consequent increase in Ca^2+^ influx, it is likely that the observed inhibition of Ca^2+^ influx by curcumin ([Fig. 2B](#f2-27-34_bt22-1){ref-type="fig"}) depends on its inhibitory effect on Syk-dependent PLCγ1 phosphorylation. In addition, to our *in vitro* results, curcumin also suppressed the IgE-dependent PSA reaction in a mast cell-dependent *in vivo* model of systemic allergic reaction ([@b34-27-34_bt22-1]) with a potency equivalent to that of the H1 histamine antagonist, Fexo ([Fig. 1A--C](#f1-27-34_bt22-1){ref-type="fig"}). We already reported that PGD~2~ and LTC~4~ play important roles in mast cell-mediated anaphylactic reaction ([@b20-27-34_bt22-1]; [@b12-27-34_bt22-1]). Recently, several reports have demonstrated that Syk kinase inhibitors promised for the treatment of allergic and antibody-mediated autoimmune diseases ([@b28-27-34_bt22-1]) and clinical implications of Syk inhibitor showed antiallergic properties when administered orally ([@b21-27-34_bt22-1]).Taken together with previous results ([@b16-27-34_bt22-1]), the anti-allergic inflammatory activity of curcumin appear to be due to the suppressions of the secretions of TNF-α and IL-4 and histamine release and eicosanoid generation through the inhibition of Syk kinase pathway in IgE/Ag-induced mast cells.
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![Curcumin inhibited IgE/Ag-induced PSA reaction. In the PSA test, ICR mice were sensitized by injecting 2 μg of IgE *i.v.* in 100 μl saline or injected with saline alone. 24 h later mice were administered 25 or 50 mg/kg of curcumin or 50 mg/kg fexofenadine-HCl (Fexo) and 1 h later were challenged with 4 mg of DNP-HSA *i.v* in 200 μl saline; blood was collected by cardiac puncture 5 min after the Ag challenge. The concentration of serum LTC~4~ (A), PGD~2~ (B), and histamine (C) were determined using appropriate enzyme immunoassay kits (Cayman Chemicals). The values indicate the mean ± S.D. from three independent experiments, ^\*\*^*p*\<0.01 versus IgE/Ag sensitized mice). Fexo (50 mg/kg) was used as an anti-histamine control drug.](BT-22-27-g001){#f1-27-34_bt22-1}

![Effect of Curcumin on LTC~4~ generation and on Ca^2+^ mobilization in IgE/Ag-activated BMMCs. IgE-sensitized BMMCs were pre-incubated with the indicated concentration of curcumin or Bay61-3606 for 1 h and then stimulated with DNP-HSA for 15 min. LTC~4~ released into the supernatant was quantified using an enzyme immunoassay kit (A). Relative intracellular Ca^2+^ levels were determined (at 5 min) (B). ^\*^*p*\<0.05, ^\*\*^*p*\<0.01 and ^\*\*\*^*p*\<0.001 versus the IgE/Ag-treated group. Results are the averages of three independent experiments.](BT-22-27-g002){#f2-27-34_bt22-1}

![Effects of curcumin and Bay 61-3606 on cPLA~2~α and 5-LO translocation and MAPKs activation. IgE-sensitized BMMCs were pre-incubated for 1 h with the indicated concentrations of curcumin or Bay 61-3606 and then stimulated with DNP-HSA for 15 min. Cytosolic and nuclear fractions were immunoblotted with antibodies for phospho-cPLA~2~α (Ser505) and 5-LO (A), and cell lysates were immunoblotted for the total and phosphorylated forms of ERK1/2, JNK and p38 (B). Immunoblots of β-actin and lamin B were used as controls for cytosol and nuclear fractions, respectively.](BT-22-27-g003){#f3-27-34_bt22-1}

![Effect of Curcumin on COX-2 dependent PGD~2~ generation and on Akt-NF-κB activation. IgE-sensitized BMMCs were pre-incubated with the indicated concentration of curcumin or Bay61-3606 for 1 h and then stimulated with DNP-HSA for 7 h. PGD~2~ released into the supernatant was quantified using an enzyme immunoassay kit and the cells were used for immunoblotting of COX-2 protein (A). IgE-sensitized BMMCs were pre-incubated with curcumin or Bay 61-3606 for 1 h and stimulated with DNP-HSA for 15 min. Then cells were taken for the immunoblot detection of Akt, IKK, IκBα cytosolic NF-κB (p65), nuclear NF-κB (p65), β-actin and lamin B. Nuclear extracts were used for the NF-κB (p65) immunoblot. Results are presented as mean ± S.D. of three independent experiments. ^\*\*^*p*\<0.01 versus the IgE/Ag-treated group.](BT-22-27-g004){#f4-27-34_bt22-1}

![Effect of curcumin on the Syk pathway. IgE-sensitized BMMCs were preincubated with curcumin or Bay 61-3606 for 1 h, and then stimulated with DNP-HSA for 5 min. Cell lysates were subjected to immunoprecipitation and immunoblot analysis for the phosphorylated forms of Syk, LAT and PLCγ1. Bay 61-3606 was used as a positive control with respect to the suppression of the Syk-mediated pathway. The relative ratios of p-Syk/Syk, p-LAT/LAT and p-PLCγ1/PLCγ1 protein levels were determined by measuring immunoblot band intensities by scanning densitometry (^\*\*^*p*\<0.01 and ^\*\*\*^*p*\<0.001). The results shown are representative of three independent experiments.](BT-22-27-g005){#f5-27-34_bt22-1}
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